Qué compañía farmacéutica genera mas "buzz"?

Astellas Pharma, which saw its buzz rise by 1,1,00 percent. Why? The drugmaker won a recommendation from an FDA advisory panel for its overactive bladder drug, prompting overactive chatter. Next up was Eli Lilly, which received FDA approval for its diagnostic imaging agent for Alzheimer’s, a controversial radiopharmaceutical that has been criticized for yielding false results.

And as the chart indicates, Pfizer followed thanks to two very different issues – Pfizer was mentioned in connection with news stories about the American Legislative Executive Council, a conservative national advocacy group that supports “Stand Your Ground” laws, such as the one being used as a defense in the Florida killing of an unarmed black teenager. Pfizer is one of many corporate members. (Más)